Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 67.60
-0.70 (-1.02%)
Jun 18, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 8.29 billion as of June 18, 2026. Its market cap has decreased by -42.41% in one year.
Market Cap
8.29B
Enterprise Value
6.71B
Revenue
38.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.60
Market Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has decreased from 8.87B to 8.29B, a decrease of -6.51%. That is a compound annual growth rate of -0.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 8.29B | -21.49% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Polaris Group | 11.74B |
| Tanvex BioPharma | 10.72B |
| Locus Cell | 9.32B |
| AP Biosciences | 8.46B |
| ACRO Biomedical | 8.44B |
| PharmaEngine | 8.23B |
| Adimmune | 7.38B |
| Acepodia | 7.11B |